AoFrio 32% revenue growth in Q3, tightens FY24 guidance
A: 78 Apollo Drive, Rosedale, Auckland 0632, New Zealand
PO Box: 302-533 North Harbour, Auckland 0751, New
Zealand
P: + 64 9 477 4500 E: info@aofrio.com
® is a registered Trademark of AoFrio Ltd.
30 October 2024
Market Announcement
For immediate release
AoFrio achieves 32% revenue growth in Q3, tightens FY24 guidance
AoFrio Limited (AOF), is providing an update on trading performance for the period ended 30 September
2024. The results show a continuation of the strong first half performance built on AoFrio’s new USA IoT
strategy and new business wins in both North America and South America.
• Revenue for the three months ended 30 September 2024 was $21.1m, a 32% increase compared
to $15.9m for Q3-2023.
• For the nine months ended 30 September 2024 (YTD 2024), revenue was $59.4m, a 29.1%
increase compared to the same period in 2023.
• IoT revenue YTD 2024 was $32.3m (54% of total revenue) with a 40.0% gross margin. Motor
revenue was $27.1m at a 16.8% gross margin.
• AOF received a $452k Research and Development Tax Incentive payment in September 2024 for
R&D activities undertaken in 2023.
• Operating costs YTD 2024 were $15.8m compared to $15.4m in 2023.
• YTD 2024 EBITDA was a surplus $2.1m, (loss of $0.3m in 2023).
• Cash at 30 September 2024 was $2.3m ($3.7m last year at 30 September).
• Borrowing at 30 September 2024 under AOF’s bank trade finance facility reduced to $3.2m from
$7.7m last year at 30 September.
On 28 August 2024, AOF launched AoFrio® INSIDE™, a first-to-market complete refrigeration solution
designed to accelerate the industry’s journey towards Net-Zero. AoFrio INSIDE offers customers the ability
to sharply reduce their fleet's energy consumption and includes data-driven tools to remotely analyse and
optimise fleets for additional efficiency gains.
In Q4-2024, AOF will launch a new 26W ECR®2 motor which can drive 250mm (10”) fans making it suitable
for evaporators and condensers for food service customers.
Two proof-of-concept trials have been completed for AOF’s first Food Retail solution, the results of which
have been very encouraging. Commercial discussions are underway to secure initial orders.
John Scott, Chairman of AOF said “The team is doing a tremendous job maintaining the revenue growth of
the previous four quarters. There are three major contributors as I see it. We are benefitting from improving
global market conditions, the environmental and energy story is resonating and the one I am most proud of is
that our team is executing well across all aspects of the business. I cannot understate the value of a high-
quality product, that arrives on time, supported by a team that is passionate and cares about its customers.
What we are seeing in the results is a combination of these factors.”
2024 Outlook
AoFrio is narrowing its revenue 2024 guidance.
Revenue in FY24 is now expected in the range $75m to $80m (previously $70m to $80m), a 16% increase
AO166
A: 78 Apollo Drive, Rosedale, Auckland 0632, New Zealand
PO Box: 302-533 North Harbour, Auckland 0751, New
Zealand
P: + 64 9 477 4500 E: info@aofrio.com
® is a registered Trademark of AoFrio Ltd.
over FY23 at the midpoint of the range. AOF is maintaining its EBITDA guidance for FY24, targeting around
$2.5m. Macroeconomic conditions may impact this guidance. AOF continues to manage its investment in
growth to align with trading conditions and expects to be able to continue expanding through internally
generated cashflows.
*EBITDA (i.e., Earnings before interest, taxation, depreciation, amortisation, and impairment) is a non-GAAP
earnings figure that equity analysts tend to focus on for comparable company performance analysis. AoFrio
considers it a valuable financial indicator because it avoids the distortions caused by differences in
amortisation and impairment policies. Contact
Ends
Contact
Greg Balla Howard Milliner
Chief Executive Officer Chief Financial Officer
Phone + 64 21938601 +64 275870455
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT reports record sales and invests for growth2024-11-20
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 21 NOVEMBER 2024 FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2024 AFT reports record s…”
- AFT — AFT Pharmaceuticals Limited: NEW YEAR LETTER TO INVESTORS2025-01-12
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 13 January 2025 NEW YEAR LETTER TO INVESTORS AFT putting building blocks in…”
- AFT — AFT Pharmaceuticals Limited: 2024 ASM Chairs address & presentation2024-08-01
“Record Revenue, Amid International Expansion and Portfolio Growth AFT PHARMACEUTICALS WORKING TO IMPROVE YOUR HEALTH7 HIGHLIGHTS •Full-year operating revenue up 25% to $195.4 million, extending a decades long record of revenue growth; •EBITDA 1 rose 22% to $26.2 million; opera…”